A 2012 evaluate of Value-performance analysis for TCM located that studies experienced low levels of evidence, without beneficial outcomes.[fifty nine] Pharmaceutical investigate around the prospective for generating new medicine from common therapies has few thriving results.[two] Proponents counsel that investigate has to this point skipped essen